Skip to content

<img width="204" height="84" src="https://www.umoja-biopharma.com/wp-content/uploads/2022/06/Umoja-Biopharma.svg" class="custom-logo astra-logo-svg" alt="Umoja Biopharma" />

Our Company
Our Science
Our Pipeline
News + Resources
Careers
Contact

Our Company
- Our Team
Our Science
Our Pipeline
News + Resources
Careers
Contact

<img width="204" height="84" src="https://www.umoja-biopharma.com/wp-content/uploads/2022/06/Umoja-Biopharma.svg" class="custom-logo astra-logo-svg" alt="Umoja Biopharma" />

Our Company
- Our Team
Our Science
Our Pipeline
News + Resources
Careers
Contact

Accessibility
Privacy Policy
Transparency in Coverage
Sitemap

Media

Years when articles were posted

June 24, 2022

Reprogramming your body may sound like science fiction, but Umoja Biopharma hopes to make it a reality.

Pharma's Almanac

June 14, 2022

Umoja and TreeFrog team up to overcome challenges facing ex vivo allogeneic therapies

BioPharma-Reporter

June 14, 2022

Umoja Biopharma Inc., of Seattle, and Treefrog Therapeutics SA, of Pessac, France, are to collaborate to address challenges facing ex vivo allogeneic therapies in immune-oncology.

Bioworld

June 11, 2022

Life sciences news: New startups, fundings, mergers, clinical trials, partnerships

GeekWire

June 2, 2022

Dallas’ Lupagen Aims To Change the Way Cancer, Other Disorders Are Treated

Dallas Innovates

Our Company
Our Science
Manufacturing
Partnerships
Our Pipeline
Careers

Press Releases
In The Media
Blog
White Papers
Presentations

1616 Eastlake Ave E.
Suite 550
Seattle, WA 98102
info@umoja-biopharma.com

Accessibility
Privacy Policy
Transparency in Coverage
Sitemap

© 2022 Umoja Biopharma. All rights reserved.